Isracann Biosciences Inc. announced that the Company has determined to advance foreign importation of Cannabis into Israel in response to perceived opportunity. Recent talks with Isracann's growing network of Israeli stakeholders, distributors and agents have resulted in the determination to leverage the Company's Canadian roots as motivation to gain approvals to establish importation as part of the Company's strategic plan. The addition of import sales will provide several positive advantages including an additional revenue stream, brand differentiation with strains not yet introduced to the Israeli market, and an ability to test internal processing facilities and trial distribution arrangements both domestically and through resales to European partners. To facilitate and expedite the process, Isracann has entered into an agreement with United Greeneries Ltd. the cultivation subsidiary of Costa Canna Group to export Canadian cannabis on an exclusive basis into Israel and with a non-exclusive agreement for entry into the European markets. Under this agreement, Isracann will enjoy an ability to source both United Greeneries grown, and Canadian 3rd party grown product, which effectively provides access to the entire Canadian marketplace.